Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The next step toward personalized recommendations for genetic cardiomyopathies

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Truncating variants in TTN and FLNC are the most prevalent causes of dilated or arrhythmogenic cardiomyopathy.


  1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997–4126.

    Article  PubMed  Google Scholar 

  2. Jacobs J, Van Aelst L, Breckpot J, Corveleyn A, Kuiperi C, Dupont M, et al., Tools to differentiate between Filamin C and Titin truncating variant carriers: value of MRI. Eur J Human Genet. 2023.

  3. Akhtar MM, Lorenzini M, Pavlou M, Ochoa JP, O’Mahony C, Restrepo-Cordoba MA, et al. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure. JAMA Cardiol. 2021;6:891–901.

    Article  PubMed  Google Scholar 

  4. Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015;7:270ra276.

    Article  Google Scholar 

  5. Verdonschot JAJ, Vanhoutte EK, Claes GRF, Helderman-van den Enden A, Hoeijmakers JGJ, Hellebrekers D, et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum Mutat. 2020;41:1091–111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references



JAJV is supported by a research grant (Dekker – Clinical Scientist) from the Dutch Heart Foundation.

Author information

Authors and Affiliations



SLVMS and JAJV both wrote the comment equally. SLVMS designed and created the figure.

Corresponding author

Correspondence to Job A. J. Verdonschot.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stroeks, S.L.V.M., Verdonschot, J.A.J. The next step toward personalized recommendations for genetic cardiomyopathies. Eur J Hum Genet (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


Quick links